Exelixis Inc (NASDAQ:EXEL) shares, rose in value, with the stock price down by -1.49% to the previous day’s close as strong demand from buyers drove the stock to $23.14.
Actively observing the price movement in the last trading, the stock closed the session at $23.49. The value of beta (5-year monthly) was 0.57 whereas the PE ratio was 35.75 over 12-month period. Referring to stock’s 52-week performance, its high was $24.34, and the low was $18.08. On the whole, EXEL has fluctuated by 3.40% over the past month.
With the market capitalization of Exelixis Inc currently standing at about $7.02 billion, investors are eagerly awaiting this quarter’s results, scheduled for Apr 30, 2024 – May 06, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0.23, which is expected to increase to $0.42 for fiscal year $1.23 and then to about $1.46 by fiscal year 2025. Data indicates that the EPS growth is expected to be 89.20% in 2025, while the next year’s EPS growth is forecast to be 18.70%.
Analysts have estimated the company’s revenue for the quarter at $453.76 million, with a low estimate of $409.2 million and a high estimate of $521 million. According to the average forecast, sales growth in current quarter could jump up 11.00%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $1.9 billion, representing an increase of 4.00% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were 1 upward and no downward review(s) in last seven days. We see that EXEL’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium term indicators have put the stock in the category of 50% Buy while long term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 1.88, with the price of EXEL currently trading nearly -0.53% and 4.54% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 51.66, while the 7-day volatility ratio is showing 1.95% which for the 30-day chart, stands at 1.93%. Furthermore, Exelixis Inc (EXEL)’s beta value is 0.57, and its average true range (ATR) is 0.49.
A comparison of Exelixis Inc (EXEL) with its peers suggests the former has fared considerably weaker in the market. EXEL showed an intraday change of -1.49% in last session, and over the past year, it grew by 18.36%%.
Data on historical trading for Exelixis Inc (NASDAQ:EXEL) indicates that the trading volumes over the past 10 days have averaged 2.18 million and over the past 3 months, they’ve averaged 2.37 million. According to company’s latest data on outstanding shares, there are 302.79 million shares outstanding.
Nearly 2.76% of Exelixis Inc’s shares belong to company insiders and institutional investors own 86.59% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 8.25 million shares as on Mar 15, 2024, resulting in a short ratio of 3.27. According to the data, the short interest in Exelixis Inc (EXEL) stood at 2.72% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 8.37 million. The stock has fallen by -3.54% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the EXEL stock heading into the next quarter.
